These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4266496)

  • 1. [Mucolipidosis of type II (I-cell disease): study of 3 cases].
    Walbaum R; Dehaene P; Scharfman W; Farriaux JP; Tondeur M; Vamos-Hurwitz E; Kint JA; van Hoof F
    Arch Fr Pediatr; 1972 Oct; 29(8):895. PubMed ID: 4266496
    [No Abstract]   [Full Text] [Related]  

  • 2. [One case of mucolipidosis type II (I. cell disease)].
    Brault A; Martin G
    Arch Fr Pediatr; 1972 Oct; 29(8):895-6. PubMed ID: 4266497
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucolipidosis II (I-cell disease): ultrastructural observations of conjunctiva and skin.
    Kenyon KR; Sensenbrenner JA
    Invest Ophthalmol; 1971 Aug; 10(8):555-67. PubMed ID: 4255137
    [No Abstract]   [Full Text] [Related]  

  • 4. Conjunctival ultrastructure in mucolipidosis 3 (pseudo-Hurler polydystrophy).
    Quigley HA; Goldberg MF
    Invest Ophthalmol; 1971 Aug; 10(8):568-80. PubMed ID: 4255138
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mucolipidosis II or I cell disease. Critical review and study of 5 personal observations].
    Farriaux JP; Walbaum R; Hongre JF; Dubois O; Louis J; Blanckaert D; Dhondt JL; Richard P; Fontaine G
    Lille Med; 1976 Jan; 21(1):51-70. PubMed ID: 815733
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mucolipidosis type II (inclusion cell disease). Study of a case and review of the literature].
    de Montis G; Garnier P; Thomassin N; Job JC; Rossier A
    Ann Pediatr (Paris); 1972 May; 19(5):369-79. PubMed ID: 4262433
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case of dysostosis multiplex with features of mucolipidosis II (I-cell disease)].
    Barylak A
    Pol Przegl Radiol Med Nukl; 1974; 38(5):617-22. PubMed ID: 4374690
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proceedings: Type II mucolipidosis. Discussion of the physiopathol problem apropos of a new case].
    Farriaux JP; Dubois O; Blanckaert D; Walbaum R; Richard P; Halle B; Fontaine G; Strecker G; Tondeur M; Leroy J; Martin JJ
    Arch Fr Pediatr; 1975 Mar; 32(3):294-5. PubMed ID: 131525
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucolipidosis II (I-cell disease). A clinical and biochemical study.
    Wiesmann UN; Vassella F; Herschkowitz NN
    Acta Paediatr Scand; 1974 Jan; 63(1):9-16. PubMed ID: 4275378
    [No Abstract]   [Full Text] [Related]  

  • 10. I-cell disease, mucolipidosis II. Pathological, histochemical, ultrastructural and biochemical observations in four cases.
    Gilbert EF; Dawson G; zu Rhein GM; Opitz JM; Spranger
    Z Kinderheilkd; 1973; 114(4):259-92. PubMed ID: 4353613
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic ultrastructure in mucolipidosis I (lipomucopolysaccharidosis).
    Freitag F; Blümcke S; Spranger J
    Virchows Arch B Cell Pathol; 1971; 7(2):189-204. PubMed ID: 4323680
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mucolipidosis type II (I-cell disease)].
    Szigeti R; Konyár E; Görgényi A; Schaff Z; Klujber L; Jellinek H
    Orv Hetil; 1975 Feb; 116(6):313-6. PubMed ID: 163018
    [No Abstract]   [Full Text] [Related]  

  • 13. [Type II mucolipidosis].
    Maroteaux P; Hors-Cayla MC; Pont J
    Presse Med (1893); 1970 Jan; 78(4):179-81. PubMed ID: 4244747
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucopolysaccharidosis type I: clinical and biochemical study.
    Bassyouni HT; Afifi HH; el-Awadi MK; Meguid NA
    East Mediterr Health J; 2000; 6(2-3):359-66. PubMed ID: 11556024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucolipidosis II (I-cell disease): present status of knowledge.
    Leroy JG; Martin JJ
    Birth Defects Orig Artic Ser; 1975; 11(6):283-93. PubMed ID: 1103995
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.
    Gallegos-Arreola MP; González-Noriega A; Zúñiga-González GM; Flores-Martínez SE; Morán Moguel MC; Figuera LE; Sánchez-Corona J
    Arch Med Res; 1997; 28(1):91-4. PubMed ID: 9078594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical studies in mucolipidoses II and III.
    Shapiro LJ; Hickman S; Hall CW; Neufeld EF
    Birth Defects Orig Artic Ser; 1975; 11(6):301-5. PubMed ID: 127631
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow transplantation in Hunter syndrome (mucopolysaccharidosis type II): two-year follow-up of the first Italian patient and review of the literature.
    Coppa GV; Gabrielli O; Zampini L; Pierani P; Giorgi PL; Jezequel AM; Orlandi F; Miniero R; Busca A; De Luca T
    Pediatr Med Chir; 1995; 17(3):227-35. PubMed ID: 7567644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of a mixture of fungal glucosidases to a patient with type II glycogenosis (Pompe's disease).
    Lauer RM; Mascarinas T; Racela AS; Diehl AM; Brown BI
    Pediatrics; 1968 Oct; 42(4):672-6. PubMed ID: 5245517
    [No Abstract]   [Full Text] [Related]  

  • 20. Mucopolysaccharidosis type II in females: case report and review of literature.
    Tuschl K; Gal A; Paschke E; Kircher S; Bodamer OA
    Pediatr Neurol; 2005 Apr; 32(4):270-2. PubMed ID: 15797184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.